A detailed history of Northern Trust Corp transactions in Chroma Dex Corp. stock. As of the latest transaction made, Northern Trust Corp holds 377,703 shares of CDXC stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
377,703
Previous 107,886 250.09%
Holding current value
$2.05 Million
Previous $294,000 368.71%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $677,240 - $1.03 Million
269,817 Added 250.09%
377,703 $1.38 Million
Q2 2024

Aug 14, 2024

BUY
$2.44 - $4.32 $18,465 - $32,693
7,568 Added 7.54%
107,886 $294,000
Q1 2024

May 14, 2024

BUY
$1.36 - $3.84 $8,478 - $23,938
6,234 Added 6.63%
100,318 $349,000
Q3 2023

Nov 13, 2023

SELL
$1.36 - $1.77 $856 - $1,115
-630 Reduced 0.67%
94,084 $137,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $1.79 $347 - $474
-265 Reduced 0.28%
94,714 $148,000
Q1 2023

May 15, 2023

BUY
$1.48 - $2.19 $6,870 - $10,165
4,642 Added 5.14%
94,979 $145,000
Q2 2022

Aug 12, 2022

SELL
$1.59 - $2.7 $538,183 - $913,896
-338,480 Reduced 78.93%
90,337 $151,000
Q1 2022

May 13, 2022

SELL
$2.02 - $3.92 $41,702 - $80,928
-20,645 Reduced 4.59%
428,817 $1.05 Million
Q4 2021

Feb 08, 2022

BUY
$3.74 - $6.7 $11,343 - $20,321
3,033 Added 0.68%
449,462 $1.68 Million
Q3 2021

Nov 15, 2021

SELL
$6.05 - $10.41 $165,407 - $284,609
-27,340 Reduced 5.77%
446,429 $2.8 Million
Q2 2021

Aug 13, 2021

BUY
$6.66 - $10.92 $197,369 - $323,614
29,635 Added 6.67%
473,769 $4.67 Million
Q1 2021

May 12, 2021

SELL
$4.59 - $18.74 $153,250 - $625,691
-33,388 Reduced 6.99%
444,134 $4.15 Million
Q4 2020

Feb 11, 2021

SELL
$3.93 - $5.5 $29,616 - $41,448
-7,536 Reduced 1.55%
477,522 $2.29 Million
Q3 2020

Nov 16, 2020

SELL
$4.01 - $5.56 $81,342 - $112,784
-20,285 Reduced 4.01%
485,058 $1.95 Million
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $37,626 - $69,231
12,542 Added 2.55%
505,343 $2.32 Million
Q1 2020

May 14, 2020

BUY
$2.54 - $4.75 $71,851 - $134,368
28,288 Added 6.09%
492,801 $1.61 Million
Q4 2019

Feb 14, 2020

BUY
$2.83 - $4.61 $52,977 - $86,299
18,720 Added 4.2%
464,513 $2 Million
Q3 2019

Nov 13, 2019

BUY
$3.83 - $4.72 $110,618 - $136,323
28,882 Added 6.93%
445,793 $1.76 Million
Q2 2019

Aug 13, 2019

BUY
$3.71 - $4.83 $11,463 - $14,924
3,090 Added 0.75%
416,911 $1.94 Million
Q1 2019

May 13, 2019

BUY
$3.2 - $4.19 $7,632 - $9,993
2,385 Added 0.58%
413,821 $1.73 Million
Q4 2018

Feb 12, 2019

BUY
$2.8 - $4.22 $14,025 - $21,137
5,009 Added 1.23%
411,436 $1.41 Million
Q3 2018

Nov 14, 2018

BUY
$3.5 - $4.91 $1 Million - $1.41 Million
287,127 Added 240.68%
406,427 $1.74 Million
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $204,141 - $280,853
63,398 Added 113.41%
119,300 $443,000
Q1 2018

May 09, 2018

BUY
$4.05 - $6.46 $57,902 - $92,358
14,297 Added 34.36%
55,902 $235,000
Q4 2017

Feb 14, 2018

BUY
$3.88 - $6.96 $3,686 - $6,612
950 Added 2.34%
41,605 $245,000
Q3 2017

Nov 13, 2017

BUY
$2.91 - $4.71 $118,306 - $191,485
40,655
40,655 $175,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $372M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.